Novartis announced plans to invest $23 billion in building and expanding 10 facilities in the US to combat potential drug import duties from the Trump administration, creating nearly a thousand new jobs. This move will allow Novartis to produce all of its key medicines in the US, positioning it ahead of potential sector-specific tariffs on pharmaceuticals. This commitment by Novartis follows similar large investments by Johnson & Johnson and Eli Lilly in anticipation of future trade challenges.
Full Article
Loss of FEMA program spells disaster for hundreds of communities and their projects
FEMA's Elimination of the BRIC Program FEMA's recent decision to eliminate the Building Resilient Infrastructure and Communities (BRIC) program has resulted in the loss of over $3.6 billion in federal funding for communities like Mount Pleasant, North Carolina, which were set to use the funds for vital infrastructure improvements aimed at disaster preparedness. Local officials, including Lafourche Parish President Archie Chaisson, have expressed dismay over the decision, emphasizing the importance of such funding for enhancing...
Read more